Figure 3.
Structures of phase I metabolites of aripiprazole (adapted from FDA document NDA No. 21-436). Dehydroaripiprazole is the major metabolite after chronic dosing, and is pharmacologically active.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.